Coldstream Capital Management Inc Fibrogen Inc Call Options Transaction History
Coldstream Capital Management Inc
- $4.64 Billion
- Q1 2025
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding FGEN
# of Institutions
75Shares Held
35.2MCall Options Held
424KPut Options Held
112K-
Armistice Capital, LLC New York, NY6.8MShares$2.18 Million0.05% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.86MShares$1.87 Million0.0% of portfolio
-
Acadian Asset Management LLC Boston, MA3.91MShares$1.25 Million0.01% of portfolio
-
Primecap Management CO Pasadena, CA3.74MShares$1.2 Million0.0% of portfolio
-
Black Rock Inc. New York, NY2.41MShares$771,0880.0% of portfolio
About FIBROGEN INC
- Ticker FGEN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 93,741,200
- Market Cap $30M
- Description
- FibroGen, Inc., a biopharmaceutical company, discovers, develops, and commercializes therapeutics to treat serious unmet medical needs. The company is developing Roxadustat, an oral small molecule inhibitor of hypoxia inducible factor prolyl hydroxylases, which has completed Phase III clinical development for the treatment of anemia in chronic k...